All the data were obtained under a diabetic condition, indicating that TGF-β–Smad3 signaling modulates the phosphorylation of the Smad1 C-terminal and linker domains simultaneously in diabetes mellitus. This evidence concerns the gene SMAD3 and diabetes mellitus.